Revision of Previously Issued Consolidated Financial Statements - Revision of Previously Issued Consolidated Financial Statements (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Mar. 31, 2025 |
Sep. 30, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Sep. 30, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Revision of Previously Issued Consolidated Financial Statements [Abstract] | |||||||||||
| Goodwill | $ 1,429 | $ 1,429 | $ 5,697 | $ 5,697 | $ 5,697 | $ 1,429 | $ 5,697 | $ 5,697 | $ 1,429 | $ 1,429 | |
| Total assets | 29,493 | 33,033 | 39,383 | 38,759 | 39,226 | 29,493 | 38,759 | 39,383 | 30,521 | 34,928 | |
| Accrued expenses and other current liabilities | 5,948 | 7,240 | 7,643 | 5,776 | 5,445 | 5,948 | 5,776 | 7,643 | 6,155 | 7,364 | |
| Total current liabilities | 12,551 | 13,600 | 13,165 | 11,301 | 11,764 | 12,551 | 11,301 | 13,165 | 26,741 | 13,396 | |
| Total liabilities | 28,961 | 30,054 | 29,981 | 29,253 | 29,792 | 28,961 | 29,253 | 29,981 | 27,613 | 29,956 | |
| Accumulated deficit | (252,841) | (250,266) | (243,589) | (241,515) | (241,424) | (252,841) | (241,515) | (243,589) | (254,405) | (248,144) | |
| Total stockholders’ equity | 532 | 2,979 | 9,401 | 9,506 | 9,434 | 532 | 9,506 | 9,401 | 2,908 | 4,972 | $ 12,688 |
| Total liabilities and stockholders’ equity | 29,493 | 33,033 | 39,383 | 38,759 | 39,226 | 29,493 | 38,759 | 39,383 | 30,521 | 34,928 | |
| General and administrative | 2,997 | 2,263 | 3,621 | 2,202 | 2,708 | 5,260 | 4,910 | 8,531 | 10,184 | 10,896 | |
| Impairment of goodwill | 0 | 4,268 | |||||||||
| Total operating expenses | 6,616 | 5,482 | 6,891 | 5,455 | 6,083 | 12,098 | 11,538 | 18,429 | 22,581 | 28,477 | |
| Loss from operations | (2,310) | (1,705) | (1,605) | (478) | (2,887) | (4,015) | (3,365) | (4,970) | (4,700) | (9,255) | |
| Net loss | $ (2,575) | $ (2,122) | $ (2,074) | $ (91) | $ (3,366) | $ (4,697) | $ (3,457) | $ (5,531) | $ (6,261) | $ (10,086) | |
| Net loss per share of common stock, basic (in Dollars per share) | $ (0.62) | $ (0.51) | $ (0.51) | $ (0.03) | $ (0.1) | $ (1.13) | $ (0.99) | $ (1.5) | $ (1.35) | $ (2.65) | |
| Net loss per share of common stock, diluted (in Dollars per share) | $ (0.62) | $ (0.51) | $ (0.51) | $ (0.03) | $ (0.1) | $ (1.13) | $ (0.99) | $ (1.5) | $ (1.35) | $ (2.65) | |
| As Previously Reported [Member] | |||||||||||
| Revision of Previously Issued Consolidated Financial Statements [Abstract] | |||||||||||
| Goodwill | $ 2,658 | $ 2,658 | $ 6,519 | $ 6,519 | $ 6,519 | $ 2,658 | $ 6,519 | $ 6,519 | $ 2,658 | ||
| Total assets | 30,722 | 34,262 | 40,205 | 39,581 | 40,048 | 30,722 | 39,581 | 40,205 | 36,157 | ||
| Accrued expenses and other current liabilities | 7,401 | 8,779 | 8,524 | 6,608 | 6,269 | 7,401 | 6,608 | 8,524 | 8,593 | ||
| Total current liabilities | 14,004 | 15,139 | 14,046 | 12,133 | 12,588 | 14,004 | 12,133 | 14,046 | 14,625 | ||
| Total liabilities | 30,414 | 31,593 | 30,862 | 30,085 | 30,616 | 30,414 | 30,085 | 30,862 | 31,185 | ||
| Accumulated deficit | (253,065) | (250,576) | (243,647) | (241,525) | (241,426) | (253,065) | (241,525) | (243,647) | |||
| Total stockholders’ equity | 308 | 2,669 | 9,343 | 9,496 | 9,432 | 308 | 9,496 | 9,343 | |||
| Total liabilities and stockholders’ equity | 30,722 | 34,262 | 40,205 | 39,581 | 40,048 | 30,722 | 39,581 | 40,205 | 36,157 | ||
| General and administrative | 2,911 | 2,573 | 3,669 | 2,210 | 2,710 | 5,484 | 4,920 | 8,589 | 11,303 | ||
| Impairment of goodwill | 3,861 | ||||||||||
| Total operating expenses | 6,530 | 5,792 | 6,939 | 5,463 | 6,085 | 12,322 | 11,548 | 18,487 | |||
| Loss from operations | (2,224) | (2,015) | (1,653) | (486) | (2,889) | (4,239) | (3,375) | (5,028) | |||
| Net loss | $ (2,489) | $ (2,432) | $ (2,122) | $ (99) | $ (3,368) | $ (4,921) | $ (3,467) | $ (5,589) | |||
| Net loss per share of common stock, basic (in Dollars per share) | $ (0.6) | $ (0.58) | $ (0.53) | $ (0.03) | $ (0.1) | $ (1.18) | $ (0.99) | $ (1.52) | |||
| Net loss per share of common stock, diluted (in Dollars per share) | $ (0.6) | $ (0.58) | $ (0.53) | $ (0.03) | $ (0.1) | $ (1.18) | $ (0.99) | $ (1.52) | |||
| Adjustment [Member] | |||||||||||
| Revision of Previously Issued Consolidated Financial Statements [Abstract] | |||||||||||
| Goodwill | $ (1,229) | $ (1,229) | $ (822) | $ (822) | $ (822) | $ (1,229) | $ (822) | $ (822) | (1,229) | ||
| Total assets | (1,229) | (1,229) | (822) | (822) | (822) | (1,229) | (822) | (822) | (1,229) | ||
| Accrued expenses and other current liabilities | (1,453) | (1,539) | (881) | (832) | (824) | (1,453) | (832) | (881) | (1,229) | ||
| Total current liabilities | (1,453) | (1,539) | (881) | (832) | (824) | (1,453) | (832) | (881) | (1,229) | ||
| Total liabilities | (1,453) | (1,539) | (881) | (832) | (824) | (1,453) | (832) | (881) | (1,229) | ||
| Accumulated deficit | 224 | 310 | 58 | 10 | 2 | 224 | 10 | 58 | |||
| Total stockholders’ equity | 224 | 310 | 58 | 10 | 2 | 224 | 10 | 58 | |||
| Total liabilities and stockholders’ equity | (1,229) | (1,229) | (822) | (822) | (822) | (1,229) | (822) | (822) | (1,229) | ||
| General and administrative | 86 | (310) | (48) | (8) | (2) | (224) | (10) | (58) | (407) | ||
| Impairment of goodwill | $ 407 | ||||||||||
| Total operating expenses | 86 | (310) | (48) | (8) | (2) | (224) | (10) | (58) | |||
| Loss from operations | (86) | 310 | 48 | 8 | 2 | 224 | 10 | 58 | |||
| Net loss | $ (86) | $ 310 | $ 48 | $ 8 | $ 2 | $ 224 | $ 10 | $ 58 | |||
| Net loss per share of common stock, basic (in Dollars per share) | $ (0.02) | $ 0.07 | $ 0.02 | $ 0 | $ 0 | $ 0.05 | $ 0 | $ 0.02 | |||
| Net loss per share of common stock, diluted (in Dollars per share) | $ (0.02) | $ 0.07 | $ 0.02 | $ 0 | $ 0 | $ 0.05 | $ 0 | $ 0.02 | |||
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of asset recognized for present right to economic benefit. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|